Dr. Raghava R. Gollapudi, MD

Dr. Gollapudi practices at San Diego Cardiac Center Medical Group Inc in San Diego, California.

Dr. Gollapudi's NPI, 1467429191, was assigned on March 1, 2006. Dr. Gollapudi graduated from Hahneman Medical College of the Pacific in 1999. Dr. Gollapudi holds California license A73392.

Dr. Gollapudi's primary practice is San Diego Cardiac Center Medical Group Inc, at 3131 Berger Ave, San Diego, CA 92123 in San Diego County. The practice phone is (858) 244-6800.

Dr. Gollapudi's primary practice is San Diego Cardiac Center Medical Group Inc in San Diego, California. Dr. Gollapudi is also affiliated with Sharp Memorial Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Gollapudi to 4 more hospitals, 4 group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gollapudi practices, 10 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Gollapudi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Gollapudi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Gollapudi's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists angioplasty, cardiac catheterization and circulation problems among the conditions Dr. Gollapudi treats.

CMS data shows 3,099 Medicare services from Dr. Gollapudi across 29 procedure codes in 2024, for 1,164 Medicare patients. Medicare paid $230,768 for them.

CMS counts 1,164 Medicare patients who saw Dr. Gollapudi in 2024. The largest group is 65 to 74, with 444 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gollapudi's median patient age at 72, with 44% women.

In 2024, Dr. Gollapudi wrote 1,542 Medicare Part D claims for 285 patients. 85% of them were for generic drugs. CMS names the drug for 1,358 of them, across 27 drugs with 11 or more claims each, at $214,919 in total drug cost. In 2023, CMS named 1,050 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Gollapudi for performance year 2024, reported as part of a group. Dr. Gollapudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gollapudi as offering telehealth. CMS counts 38 procedures of coronary angioplasty and stenting by Dr. Gollapudi, more than 74% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Gollapudi, published from 2006 to 2017. 2017 was the busiest year, with 2. The most frequent topics are Coronary Artery Disease, Coronary Restenosis and Algorithms. Dr. Gollapudi has published most often in Am J Cardiol. Dr. Gollapudi's most frequent co-authors are Steve S. Lee, MD, Surendra B. Avula, MD and Wayne B. Batchelor, MD.

Dmand AI links Dr. Gollapudi to 5 clinical trials. 4 are still active or recruiting. Conditions studied include Coronary Artery Disease, Essential Hypertension and Foramen Ovale, Patent. Abbott Medical Devices sponsors the most, 3.

CMS Open Payments shows 1,188 general payments to Dr. Gollapudi from 68 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. Abbott Laboratories paid the most, $225,035.

Dr. Gollapudi graduated from Hahneman Medical College of the Pacific in 1999.

Dr. Gollapudi is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.